In summary, we identified FTO as a potential oncogene in colorectal cancer cells and we demonstrated that targeting FTO significantly suppressed cancer cell proliferation, migration and invasion in vitro and tumor progression in vivo. The gene discussed is FTO; the disease is neoplasm.